Background: The Freestyle stentless bioprosthesis (FSB) has been demonstrated to be a durable prosthesis in the aortic position. We present data following Freestyle implantation for up to 10 years post-operatively and compare this with previously published results. Methods: A retrospective cohort analysis of 237 patients following FSB implantation occurred at five Australian hospitals. Follow-up data included clinical and echocardiographic outcomes. Results: The cohort was 81.4% male with age 63.2±13.0 years and was followed for a mean of 2.4±2.3 years (range 0-10.9 years, total 569 patient-years). The FSB was implanted as a full aortic root replacement in 87.8% patients. The 30-day all cause mortality was 4.2% (2.0% for elective surgery). ...
Objectives The aims of this study were to compare long-term results after homograft versus Freestyle...
BACKGROUND: The stentless Freedom Solo aortic bioprosthesis is implanted supraannularly using one ru...
Background. Aortic valve disease is increasing among the elderly and aortic valve replacement is the...
ObjectiveStentless xenograft bioprostheses may be the future valve of choice for aortic valve replac...
AbstractObjectivesWe sought to describe the hemodynamic and clinical outcomes for the Freestyle aort...
Background and Aim: Early and mid-term clinical outcomes after aortic valve replacement (AVR) with s...
EZELSOY, MEHMET/0000-0002-8423-5071WOS: 000518864700007PubMed: 32118540Background: the study is pres...
Stentless bioprostheses show excellent early hemodynamic performance. However, longevity still remai...
Background: The Medtronic Freestyle bioprosthesis (FSB) provides an alternative to other prostheses ...
Objectives: Our objective was to examine intermediate-term survival and reinterventions in unselecte...
BACKGROUND: Bioprostheses (BPs) are used to avoid anticoagulation after aortic valve replacement (AV...
International audienceBACKGROUND: We evaluate the clinical results of the Carpentier-Edwards supraan...
Background: We compared the midterm outcome after aortic valve replacement with the Freestyle stentl...
Objective: The objective of this study was to report midterm clinical outcomes with a self-expandabl...
Objective: Midterm clinical outcome was evaluated after aortic root replacement with Freestyle ® ste...
Objectives The aims of this study were to compare long-term results after homograft versus Freestyle...
BACKGROUND: The stentless Freedom Solo aortic bioprosthesis is implanted supraannularly using one ru...
Background. Aortic valve disease is increasing among the elderly and aortic valve replacement is the...
ObjectiveStentless xenograft bioprostheses may be the future valve of choice for aortic valve replac...
AbstractObjectivesWe sought to describe the hemodynamic and clinical outcomes for the Freestyle aort...
Background and Aim: Early and mid-term clinical outcomes after aortic valve replacement (AVR) with s...
EZELSOY, MEHMET/0000-0002-8423-5071WOS: 000518864700007PubMed: 32118540Background: the study is pres...
Stentless bioprostheses show excellent early hemodynamic performance. However, longevity still remai...
Background: The Medtronic Freestyle bioprosthesis (FSB) provides an alternative to other prostheses ...
Objectives: Our objective was to examine intermediate-term survival and reinterventions in unselecte...
BACKGROUND: Bioprostheses (BPs) are used to avoid anticoagulation after aortic valve replacement (AV...
International audienceBACKGROUND: We evaluate the clinical results of the Carpentier-Edwards supraan...
Background: We compared the midterm outcome after aortic valve replacement with the Freestyle stentl...
Objective: The objective of this study was to report midterm clinical outcomes with a self-expandabl...
Objective: Midterm clinical outcome was evaluated after aortic root replacement with Freestyle ® ste...
Objectives The aims of this study were to compare long-term results after homograft versus Freestyle...
BACKGROUND: The stentless Freedom Solo aortic bioprosthesis is implanted supraannularly using one ru...
Background. Aortic valve disease is increasing among the elderly and aortic valve replacement is the...